BackgroundClinical trials demonstrated high efficacy of daily and event-driven oral pre-exposure prophylaxis (PrEP) in HIV prevention. Event-driven PrEP involves taking two tablets before and two times one tablet after sexual contact (2-1-1/on-demand). While both are implemented in Dutch clinical practice, evaluating real-world effectiveness requires large-scale data from routine clinical care.
Increased HIV incidence during Event-Driven PrEP compared to Daily PrEP in the Netherlands
calendar_today
August 17, 2026
person
Willemstein, I. J. M., Prins, M., Heijne, J. C. M., Davidovich, U., Schim van der Loeff, M. F., Chaname Pinedo, L., Akwiwu, E. U., van Benthem, B. H. B., Hoornenborg, E., Jongen, V. W.
domain
medrxiv